ビリルビンはヘム生物合成を阻害する

R F LABBE, M R ZASKE, R A ALDRICH

Science (New York, N.Y.)

|June 26, 1959

まとめ

プロトポルフィリンからのヘム合成は,ビリルビンによって抑制されます. この胆汁の色素は,プロトポルフィリンと競合し,ヘム産生に影響を与え,ハイパービリルビルビネミアのような状態を潜在的に説明します.

科学分野:

バイオケミストリーバイオケミストリー
酵素学酵素学とは
ヘム代謝についてです.

背景:

ヘムは細胞呼吸と酸素輸送に不可欠です.
ヘム合成の障害は,様々な病理を引き起こす可能性があります.
ハイパービリルビリン血症は,ビリルビンの濃度の上昇によって特徴づけられる状態です.

研究の目的:

プロトポルフィリンと鉄の酵素によるヘムへの変換を調査する.
このヘム合成経路に対するビリルビンの影響を決定するために.
ハイパービリルビリン血症におけるビリルビンの効果の影響を調査する.

主な方法:

ネズミの肝臓から溶解可能な酵素を調製し,ヘム形成を触媒化する.
ヘム産生を測定するインビトロ酵素測定法.
ビリルビリンによる阻害のメカニズムを解明するための運動分析.

主要な成果:

この酵素は,プロトポルフィリンと鉄のヘムへの変換を成功裏に触媒化した.
ビリルビンは,この酵素反応を抑制することが判明しました.
運動データは,プロトポルフィリンとビリルビンの間の競争的抑制を示した.

結論:

ビリルビンは,ヘム合成を司る酵素を競争的に抑制する.
この抑制メカニズムは,高bilirubinemiaの病理生理学に貢献することができます.
この相互作用を理解することは,ヘム関連疾患の管理に不可欠です.

キーワード:

ビリルービン (BILIRUBIN) /効果についてヘモグロビンはヘモグロビンです.肝臓/代謝について

さらに関連する動画

09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

10:05

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Published on: May 8, 2020

関連する概念動画

01:14

Erythropoiesis

Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...

01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...

01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...

01:14

Erythropoiesis

01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...

01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...

関連する実験動画

ビリルビンはヘム生物合成を阻害する

科学分野:

背景:

研究 の 目的:

主な方法:

主要な成果:

結論:

さらに関連する動画

関連する概念動画